These success, together with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assistance the notion of targeting ACKR3 as a singular strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-connected disorders.Identify your assortment: Identify must